Canada to allow import of J&J vaccine doses made at Emergent facility
By Syndicated ContentNov 24, 2021 | 10:23 AM
(Reuters) – The Canadian health regulator said on Wednesday it would allow Johnson & Johnson to import its COVID-19 vaccine made at contract manufacturer Emergent BioSolutions Inc’s plant in Baltimore, Maryland.
(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (517) 279-1590.
